zidovudine has been researched along with ATLL in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (18.03) | 18.2507 |
2000's | 24 (39.34) | 29.6817 |
2010's | 20 (32.79) | 24.3611 |
2020's | 6 (9.84) | 2.80 |
Authors | Studies |
---|---|
Agostini, A; Avallone, G; Calcagno, A; Caracciolo, D; Fierro, MT; Mastorino, L; Merli, M; Quaglino, P; Ribero, S; Rubatto, M; Senetta, R; Trunfio, M | 1 |
Heilman, E; Olayinka, JT; Vatanchi, M | 1 |
Chen, J; Chen, Q; Chen, RL; Lin, Y; Wu, Y; Zhang, RD | 1 |
Haghi, S; Hasani, M; Mardi, S; Mozhgani, SH; Seighali, N; Shadabi, S; Shafiee, A; Shojaeian, S; Taherzadeh-Ghahfarokhi, N | 1 |
Cook, LB; Phillips, AA | 1 |
Aguilar, C; Avettand-Fenoel, V; Bougnoux, ME; Frenzel, L; Guery, R; Helias, P; Hermine, O; Lanternier, F; Lecuit, M; Lecuyer, H; Lortholary, O; Marçais, A; Raphalen, JH; Renaudier, P; Santa, F; Sibon, D; Suarez, F | 1 |
Dittus, C; Sloan, JM | 1 |
Bazarbachi, A; Hermine, O; Marçais, A; Nasr, R | 1 |
Chen, H; Cui, J; Du, Z; Hoffman, AR; Hu, JF; Li, W; Ye, S; Yu, D | 1 |
Bangham, CRM; Cook, LB; Demontis, MA; Gillet, NA; Greiller, C; Melamed, A; Rowan, AG; Sagawe, S; Taylor, GP; Witkover, A | 1 |
Tobinai, K; Tsukasaki, K | 1 |
Bazarbachi, A; Berry, F; Dassouki, Z; de Thé, H; El Hajj, H; Ezzedine, M; Farid, R; Ghantous, A; Ghavamzadeh, A; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Mortada, M; Nasser, R; Rafatpanah, H; Rahimi, H; Rezaee, R; Shirdel, A; Tarhini, M | 1 |
Fukushima, T | 1 |
Chihara, D; Choi, I; Seto, M; Utsunomiya, A | 1 |
Deligny, C; Donnio, A; Hage, R; Jean-Charles, A; Meniane, JC; Merle, H; Plumelle, Y | 1 |
Barbosa, HS; Bittencourt, AL; Farre, L; Pimenta, A | 1 |
Grossman, ME; Husain, S; MacGregor-Cortelli, B; Marneros, AG; Neylon, E; Nuovo, GJ; O'Connor, OA; Patterson, M; Silvers, DN; Zain, JM | 1 |
Bazarbachi, A; de Thé, H; El Hajj, H; Farid, R; Hatoum, H; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Maleki, M; Rafatpanah, H; Rahimi, H; Rezaee, SA; Shirdel, A; Tarhini, M; Wattel, E; Yazdi, MT | 1 |
Bazarbachi, A; Bitar, N; Hajj, HE; Houmani, Z; Mahfouz, R; Otrock, ZK; Sabbah, A; Zaatari, G | 1 |
Tsukasaki, K | 2 |
Bittencourt, AL; Farré, L; Mota, K; Oliveira, RF | 1 |
Alizadeh, AA; Bohen, SP; Cubedo-Gil, E; Harrington, WJ; Lossos, C; Lossos, IS; Martinez-Climent, JA; Ramos, JC | 1 |
Gessain, A; Mahieux, R | 1 |
Agbalika, F; Cassar, O; Duval, A; Gessain, A; Moulonguet, I; Petit, A; Rivet, J; Wallach, D | 1 |
Bazarbachi, A; Carlos Ramos, J; Gessain, A; Harrington, W; Hermine, O; Otrock, Z; Panelatti, G; Plumelle, Y; Taylor, G; Tortevoye, P | 1 |
Fukushima, T; Ishitsuka, K; Tobinai, K; Tsukasaki, K | 1 |
Fujikane, H; Fujita, M; Hara, S; Ishitsuka, K; Ishizu, M; Katsuya, H; Kunami, N; Ogata, K; Sasaki, H; Takamatsu, Y; Tamura, K; Toyota, T; Uchiyama, M | 1 |
Ishitsuka, K; Tamura, K; Tsukasaki, K | 1 |
Grubb, B; Henderson, DB; Pandya, AG | 1 |
Ardeshna, KM; Crichton, S; Cwynarski, K; Fields, PA; Hodson, A; Kumaran, T; Matutes, E; Mir, N; Montoto, S; Pagliuca, A; Taylor, GP | 1 |
Gallo, RC | 2 |
Au, BC; Devine, S; Foley, R; Fowler, DH; Lee, CJ; Lopez-Perez, O; Medin, JA; Neschadim, A; Pacienza, N; Scaife, M; Scheid, E; Wang, JC | 1 |
Arnulf, B; Bazarbachi, A; Besson, C; Gonin, C; Hermine, O; Panelatti, G; Plumelle, Y | 1 |
Allard, I; Arnulf, B; Bazarbachi, A; Gessain, A; Hermine, O; Lévy, V | 1 |
Besson, C; Brebion, A; Delaunay, C; Gonin, C; Hermine, O; Panelatti, G; Plumelle, Y | 1 |
Arnulf, B; Bazarbachi, A; Brouet, JC; Damaj, G; de Thé, H; Degos, L; Delarue, R; Dombret, H; Fermand, JP; Hermine, O; Lefrère, F; Poupon, J; Rousselot, P; Varet, B | 1 |
Anargyrou, K; Dimitrakopoulou, AD; Kokoris, SI; Kontopidou, FN; Korkolopoulou, P; Kyrtsonis, MC; Legakis, N; Pangalis, GA; Siakantaris, MP; Spanakis, N; Tsakris, A; Vassilakopoulos, TP; Viniou, NA | 1 |
Aouba, A; Bazarbachi, A; Divine, M; Hermine, O; Lambotte, O; Valensi, F; Varet, B; Vasiliu, V | 1 |
Baiocchi, RA; Banks, A; Byrd, JC; Caligiuri, MA; Cruz, J; Eisenbeis, CF; Mone, A; Porcu, P; Puhalla, S; Vukosavljevic, T; Whitman, S | 1 |
Bazarbachi, A; Bellon, M; Canioni, D; Datta, A; Hermine, O; Lepelletier, Y; Nicot, C; Sinha-Datta, U; Waldmann, TA | 1 |
Almeida, FA; Chiba, AK; Colleoni, GW; Fernandes, MA; Michalany, NS; Petri, V; Pombo-de-Oliveira, MS; Sakamoto, FH; Teixeira, SP; Yamamoto, M | 1 |
Andela, V; Brites, C; Byrne, GE; Harhaj, EW; Harrington, WJ; Lossos, IS; Pedroso, C; Ramos, JC; Ratner, L; Reis, IM; Ruiz, P; Toomey, NL | 1 |
Bazarbachi, A; Farid, R; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Makhoul, NJ; Rafatpanah, H; Rastin, M; Shirdel, A; Tarhini, M; Zalloua, PA | 1 |
Augustyniak, C; Evens, AM; Gordon, LI; Gupta, R; Mehta, J; Ziegler, SL | 1 |
Kobayashi, Y; Shimoyama, M; Tobinai, K | 1 |
Pagano, JS | 1 |
Allen, S; Bennett, JM; Bernstein-Singer, M; Cabral, L; Espina, BM; Gill, PS; Harrington, W; Kaplan, MH; Liebman, HA; Ribeiro, RC | 1 |
Bouscary, D; Buzyn-Veil, A; Dreyfus, F; Franck, N; Gessain, A; Hermine, O; Leblond, V; Macintyre, E; Rio, B; Turlure, P | 1 |
Oh-hara, T; Tsuruo, T; Yusa, K | 1 |
Sauer, H | 1 |
Etoh, K; Matsuoka, M; Suzushima, H; Takatsuki, K; Tamiya, S | 1 |
Chan, EF; Dowdy, YG; Fox, KR; Lee, B; Levy, RJ; McKenna, WG; Rook, AH; Wasik, MA | 1 |
Charlotte, F; Chosidow, O; Dega, H; Francès, C; Herson, S; Leblond, V | 1 |
Bazarbachi, A; Chelbi-Alix, MK; Darwiche, N; Dbaibo, G; de Thé, H; Dianoux, L; El-Sabban, ME; Gessain, A; Hermine, O; Kersual, J; Mahé, A; Mahieux, R; Nasr, R; Zermati, Y | 1 |
Bareford, D; Cavenagh, J; Domingo, A; Hamblin, M; Kelsey, S; Matutes, E; Mir, N; Pagliuca, A; Reilly, JT; Taylor, GP | 1 |
Cranston, B; Derby, M; Eicher, D; Fleisher, TA; Hanchard, B; Herring, B; Jackson-Booth, PG; Jain, A; Lee, CC; Lucy, D; Maher, VE; Marshall, M; Nelson, DL; Stewart, DM; Top, LE; Waldmann, TA; Wharfe, G; White, JD | 1 |
Aramideh, M; Koelman, JH; Koopmans, RP; Stam, J | 1 |
Bazarbachi, A; Hermine, O | 1 |
Isono, T; Ogawa, K; Seto, A | 1 |
12 review(s) available for zidovudine and ATLL
Article | Year |
---|---|
Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
Topics: Adult; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Zidovudine | 2023 |
Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Topics: Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Human T-lymphotropic virus 1; Humans; Immunologic Factors; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Neoplasm Proteins; Receptors, CCR4; Viral Vaccines; Zidovudine | 2017 |
Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Arsenic Trioxide; Arsenicals; Female; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Oxides; Receptors, CXCR4; Zidovudine | 2017 |
Biology and treatment of HTLV-1 associated T-cell lymphomas.
Topics: Acute Disease; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Child; Chronic Disease; Clinical Trials as Topic; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Japan; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell; Zidovudine | 2013 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
Recent advances in the treatment of adult T-cell leukemia-lymphomas.
Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Cell- and Tissue-Based Therapy; Hematopoietic Stem Cell Transplantation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunotherapy; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Molecular Targeted Therapy; Receptors, CCR4; Reverse Transcriptase Inhibitors; Zidovudine | 2015 |
Adult T-cell leukemia/lymphoma and HTLV-1.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Daclizumab; Drug Resistance, Neoplasm; Endemic Diseases; Female; Gene Products, tax; Genes, pX; Human T-lymphotropic virus 1; Humans; Immunoglobulin G; Immunophenotyping; Immunotherapy; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Oxides; Paraparesis, Tropical Spastic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2007 |
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Chi-Square Distribution; Female; Humans; Interferon-alpha; Kaplan-Meier Estimate; Leukemia-Lymphoma, Adult T-Cell; Male; Martinique; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Survivors; Time Factors; Treatment Outcome; United Kingdom; United States; Young Adult; Zidovudine | 2010 |
[International consensus on the management of adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; International Cooperation; Leukemia-Lymphoma, Adult T-Cell; Prednisolone; Prognosis; Transplantation, Homologous; Vincristine; Zidovudine | 2010 |
Interferon alfa and antiretroviral agents: a treatment option for adult T-cell leukemia/lymphoma.
Topics: Anti-HIV Agents; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 2011 |
Research and discovery of the first human cancer virus, HTLV-1.
Topics: Adult; Animals; Antiviral Agents; Arsenic; Cell Proliferation; Cell Transformation, Viral; Host-Pathogen Interactions; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Transgenic; Viral Proteins; Virus Replication; Zidovudine | 2011 |
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Oxides; Retinoids; Tumor Virus Infections; Zidovudine | 2001 |
5 trial(s) available for zidovudine and ATLL
Article | Year |
---|---|
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Synergism; Female; Gastrointestinal Diseases; Hematologic Diseases; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Proviruses; Remission Induction; Viral Load; Zidovudine | 2009 |
A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Survival Analysis; Treatment Outcome; Zidovudine | 2002 |
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Female; Human T-lymphotropic virus 1; Humans; Injections, Intravenous; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Oxides; Prognosis; Recurrence; Treatment Outcome; Zidovudine | 2004 |
Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Zidovudine | 1995 |
The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Recombinant Proteins; Remission Induction; Skin Tests; Thrombocytopenia; Treatment Outcome; Zidovudine | 2001 |
44 other study(ies) available for zidovudine and ATLL
Article | Year |
---|---|
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Human T-lymphotropic virus 1; Humans; Interferon alpha-2; Italy; Leukemia-Lymphoma, Adult T-Cell; Male; Nigeria; Skin Neoplasms; Zidovudine | 2021 |
Assessing smoldering adult T cell leukemia/lymphoma: a case report.
Topics: Anti-Retroviral Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Humans; Hyperpigmentation; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Skin; Zidovudine | 2021 |
[Clinical Study of Chemotherapy Combined with Antivirals for Adult T-cell Leukemia/Lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Humans; Interferon alpha-2; Ki-67 Antigen; Lactate Dehydrogenases; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Oxidoreductases; Vincristine; Zidovudine | 2022 |
How I treat adult T-cell leukemia/lymphoma.
Topics: Aged; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prednisone; Raltegravir Potassium; Recurrence; Remission Induction; Therapies, Investigational; Vincristine; Virus Activation; Zidovudine | 2021 |
Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Febrile Neutropenia; Female; Fever of Unknown Origin; Fungemia; Humans; Interferon-alpha; Invasive Fungal Infections; Kaplan-Meier Estimate; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Prevalence; Prognosis; Retrospective Studies; Strongyloidiasis; Treatment Outcome; Young Adult; Zidovudine | 2021 |
Targeting Jurkat T Lymphocyte Leukemia Cells by an Engineered Interferon-Alpha Hybrid Molecule.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Genes, Synthetic; Genetic Engineering; Humans; Interferon-alpha; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Peptide Library; Peptides; STAT1 Transcription Factor; T-Lymphocytes; Zidovudine | 2017 |
Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma.
Topics: Adult; Allografts; Antiviral Agents; Bone Marrow Transplantation; Chronic Disease; Combined Modality Therapy; Drug Therapy, Combination; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm, Residual; Remission Induction; Time Factors; Zidovudine | 2018 |
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Cytokines; Female; Gene Expression Profiling; HTLV-I Infections; Humans; Immunologic Factors; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Prospective Studies; Treatment Outcome; Zidovudine | 2013 |
RETINAL MANIFESTATIONS IN ADULT T-CELL LEUKEMIA/LYMPHOMA RELATED TO INFECTION BY THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Eye Infections, Viral; Fatal Outcome; Female; Fluorescein Angiography; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Retinal Neoplasms; Retrospective Studies; Reverse Transcriptase Inhibitors; Zidovudine | 2016 |
A case of adult T-cell leukemia/lymphoma (ATL) with a survival of more than 13 years.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Human T-lymphotropic virus 1; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Lymphocytosis; Male; Prednisone; Treatment Outcome; Vincristine; Zidovudine | 2008 |
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Doxorubicin; Drug Eruptions; Epidermis; Etoposide; Exanthema; Folic Acid Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Recombinant Proteins; Vincristine; Zidovudine | 2009 |
Adult T-cell leukemia/lymphoma in the Middle East: first report of two cases from Lebanon.
Topics: Adult; Antiviral Agents; Bone Density Conservation Agents; Diphosphonates; Fatal Outcome; Female; Gene Products, tax; Humans; Imidazoles; Interferon-alpha; Lebanon; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Zidovudine; Zoledronic Acid | 2009 |
[Treatment for adult T-cell leukemia-lymphoma].
Topics: Antineoplastic Agents; Combined Modality Therapy; Drug Discovery; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Oncolytic Virotherapy; Prognosis; Survival Rate; Zidovudine | 2009 |
A dyshidrosis-like variant of adult T-cell leukemia/lymphoma with clinicopathological aspects of mycosis fungoides. A case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetes Mellitus; Diagnosis, Differential; Doxorubicin; Eczema, Dyshidrotic; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunohistochemistry; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Mycosis Fungoides; Polymerase Chain Reaction; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2009 |
Expression profiles of adult T-cell leukemia-lymphoma and associations with clinical responses to zidovudine and interferon alpha.
Topics: Adult; Anti-HIV Agents; Biomarkers, Tumor; Comparative Genomic Hybridization; Drug Therapy, Combination; Gene Expression Profiling; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; Zidovudine | 2010 |
Atypical presentation of adult T-cell leukaemia/lymphoma due to HTLV-1: prurigo nodularis lasting twelve years followed by an acute micropapular eruption.
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Antiviral Agents; Biopsy; CD4-Positive T-Lymphocytes; Human T-lymphotropic virus 1; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2 Receptor alpha Subunit; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prurigo; Recombinant Proteins; Skin; Time Factors; Treatment Outcome; Zidovudine | 2010 |
Is zidovudine and interferon-alfa the gold standard for adult T-cell leukemia-lymphoma?
Topics: Adult; Antineoplastic Agents; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 2010 |
Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma: case reports of Japanese patients.
Topics: Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Interferon-alpha; Japan; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Pilot Projects; Receptors, Interleukin-2; Recurrence; Treatment Outcome; Zidovudine | 2010 |
Adult T-cell lymphoma/leukemia presenting as pagetoid reticulosis of the palms and soles.
Topics: Adult; Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diagnosis, Differential; Diagnostic Errors; Doxorubicin; Etoposide; Fatal Outcome; Foot; Hand; Humans; Interferons; Jamaica; Leukemia-Lymphoma, Adult T-Cell; Male; Methotrexate; Pagetoid Reticulosis; Prednisone; Skin Neoplasms; Vincristine; Zidovudine | 2011 |
Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Retrospective Studies; Survival Analysis; Young Adult; Zidovudine | 2011 |
Engineered human Tmpk fused with truncated cell-surface markers: versatile cell-fate control safety cassettes.
Topics: Animals; Antigens, CD19; Cell Death; Cell Line, Tumor; Fabry Disease; Genetic Vectors; HEK293 Cells; Humans; Lentivirus; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Nucleoside-Phosphate Kinase; Protein Engineering; Receptor, Nerve Growth Factor; Recombinant Fusion Proteins; Transformation, Genetic; Zidovudine | 2013 |
[Adult T-cell leukemia/lymphoma. Therapeutic aspects].
Topics: Anti-HIV Agents; Antineoplastic Agents; Disease Progression; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Pain; Recurrence; Zidovudine | 2001 |
Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine; Zalcitabine; Zidovudine | 2002 |
Adult T-cell leukemia/lymphoma (ATLL): report of two fully documented Hellenic patients.
Topics: CD4-Positive T-Lymphocytes; DNA, Viral; Family Health; Female; Greece; Human T-lymphotropic virus 1; Human T-lymphotropic virus 2; Humans; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Polymerase Chain Reaction; Serologic Tests; Zidovudine | 2004 |
Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T-cell leukemia/lymphoma: efficacy of anti-retroviral and interferon therapy.
Topics: Antineoplastic Agents; Antiviral Agents; Drug Therapy, Combination; Female; Histiocytosis; Humans; Interferon-alpha; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Zidovudine | 2004 |
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia.
Topics: Alemtuzumab; Anti-HIV Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antigens, CD; Antigens, Neoplasm; Antineoplastic Agents; CD52 Antigen; Female; Glycoproteins; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Recovery of Function; T-Lymphocytes; Tumor Suppressor Protein p53; Viral Load; Zidovudine | 2005 |
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.
Topics: Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Human T-lymphotropic virus 1; Humans; Intracellular Signaling Peptides and Proteins; Leukemia-Lymphoma, Adult T-Cell; Mutation; Recurrence; Telomerase; Telomere; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53; Zidovudine | 2006 |
Cutaneous T-cell lymphoma with HTLV-I infection: clinical overlap with adult T-cell leukemia/lymphoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brazil; Cyclophosphamide; DNA, Viral; Doxorubicin; Endemic Diseases; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Prednisone; Vincristine; Zidovudine | 2006 |
IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; DNA-Binding Proteins; Drug Resistance, Viral; Gene Expression; Genes, rel; Humans; Interferon Regulatory Factors; Interferon Type I; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; NF-kappa B; Nuclear Proteins; Proto-Oncogene Mas; Proto-Oncogene Proteins c-rel; Recombinant Proteins; Zidovudine | 2007 |
Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Iran; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Proviruses; Treatment Outcome; Vascular Endothelial Growth Factor A; Viral Load; Zidovudine | 2007 |
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Central Nervous System Neoplasms; Diphtheria Toxin; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Interferons; Interleukin-2; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Recombinant Fusion Proteins; Recurrence; Remission Induction; Transplantation, Homologous; Zidovudine | 2007 |
Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma. Lymphoma Study Group of the Japan Clinical Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 1995 |
Interferon alfa and zidovudine in adult T-cell leukemia-lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 1995 |
Brief report: treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Recurrence; Remission Induction; Zidovudine | 1995 |
A surprising advance in the treatment of viral leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Gene Products, tax; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 1995 |
Induction of resistance to 1-beta-D-arabinofuranosylcytosine in human H9 cell line by simian immunodeficiency virus.
Topics: Cell Division; Cell Line; Cell Survival; Cytarabine; Cytidine Deaminase; Drug Resistance; Fluorouracil; Humans; Leukemia-Lymphoma, Adult T-Cell; Mercaptopurine; Simian Immunodeficiency Virus; Tetrahydrouridine; Tumor Cells, Cultured; Vidarabine; Zalcitabine; Zidovudine | 1995 |
[With interferon and zidovudine against therapy refractory T-cell leukemias].
Topics: Antiviral Agents; Combined Modality Therapy; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Zidovudine | 1995 |
Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells.
Topics: Adult; Aged; Alleles; Antibodies, Monoclonal; Antineoplastic Agents; Antiviral Agents; Apoptosis; Cyclophosphamide; DNA Mutational Analysis; DNA, Neoplasm; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Exons; fas Receptor; Fatal Outcome; Gene Expression Regulation, Leukemic; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Neoplasm Proteins; Neoplastic Stem Cells; Neutrophils; Polymerase Chain Reaction; Prednisone; RNA, Messenger; RNA, Neoplasm; Sequence Deletion; T-Lymphocytes; Vincristine; Zidovudine | 1998 |
A novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etretinate; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Skin; Zidovudine | 1999 |
Unsuccessful association of zidovudine and interferon alpha for acute adult T-cell leukemia lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Female; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Neoplasm Recurrence, Local; Treatment Outcome; Zidovudine | 1999 |
Evidence against a direct cytotoxic effect of alpha interferon and zidovudine in HTLV-I associated adult T cell leukemia/lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Apoptosis; Biomarkers, Tumor; Cell Survival; Combined Modality Therapy; DNA, Neoplasm; Drug Synergism; Female; Human T-lymphotropic virus 1; Humans; Immunologic Factors; Interferon-alpha; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Neoplastic Stem Cells; Remission Induction; T-Lymphocytes; Tumor Cells, Cultured; Zidovudine | 2000 |
Interferon alpha and zidovudine therapy in adult T-cell leukaemia lymphoma: response and outcome in 15 patients.
Topics: Adult; Aged; Anti-HIV Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Survival Analysis; Survival Rate; Zidovudine | 2001 |
Rapidly progressing peripheral neuropathy with lactic acidosis and coproporphyria in a patient with HTLV-I associated T-cell leukaemia treated with zidovudine.
Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Disease Progression; Female; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Mitochondria; Peripheral Nervous System Diseases; Porphyrias; Zidovudine | 2001 |
Antiviral effect of zidovudine in the experimental model of adult T cell leukemia in rabbits.
Topics: Animals; Cell Line, Transformed; Cell Transformation, Viral; Disease Models, Animal; Human T-lymphotropic virus 1; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Polymerase Chain Reaction; Proviruses; Rabbits; Tumor Cells, Cultured; Zidovudine | 1990 |